Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Global Biobanking Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025

  • Report Summary
  • Table of Contents
  • Enquiry Before Buying

Report Summary

The global biobanking market is expected to grow significantly from USD 2,207.8 million in 2018 to USD 3,600.3 million in 2025, at a CAGR of 7.3% from 2019 to 2025. Factors driving the market growth are; growing scientific research and development activities, and rising prevalence of chronic diseases. Moreover, other factors contributing to the growth of market include; favorable government initiative and investments, and growth of translational research and personalized medicine.

Biobanking is a collective term, which describes the process by which biological samples and associated data are collected, transferred, and stored for future research. It plays an important role in enabling researchers to develop therapies for chronic diseases. Moreover, hospitals, pharmaceutical and biotechnological companies, and research institutions have identified the key role Biobanking can play in the research for new diseases treatment. However, high cost of automation, and lack of public awareness may hamper the market growth to some extent.

The years used for the assessment are as follows;

  • Historical year :2015, 2016 and 2017
  • Base year  : 2018
  • Forecast period: 2019 – 2025

Biobanking Market – Regional insight

North America held the major share of the global Biobanking Market in 2018. The growth is attributed to the growing research and development activities and advancements in drug discovery. Moreover, growing number of biobanks, government initiatives, and presence of major players in the region is further augmenting the industry growth. The growth of biobanking market in Europe is attributed to the growing range of clinical research and genome epidemiology studies. Furthermore, rising investments by public and private players are further propelling the market growth in the region.

RESEARCH METHODOLOGY

The research and analysis are based on data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the biobanking market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the biobanking market
  • Finalizing the overall size and share for the global biobanking market

OBJECTIVES:

  • To classify global biobanking market into segments on the basis of product and services, sample type, storage type, application, end-user and region to analyze their growth prospects individually
  • To analyze market trends, opportunities, drivers and restraints associated with biobanking
  • Profiling key companies operating in the global biobanking market
  • To study market response with respect to the mergers and acquisitions in the industry

Table of Contents

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Global Biobanking- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global biobanking market

3.4. Value Chain Analysis

3.5. Regulation Overview

3.6. Market opportunities & trends

3.6.1. Advancements in genetics, information technology, and cell-line research

3.7. Market dynamics

3.7.1. Market driver analysis

   3.7.1.1. Growing developments in the area of metagenomics, genomics, disease biology, and personalized medicine

   3.7.1.2. Rising prevalence of chronic diseases

   3.7.1.3. Growing government initiatives and investments

3.7.2. Market restraint analysis

   3.7.2.1. High cost of automation

   3.7.2.2. Lack of public awareness

CHAPTER 4. Competitive Outlook

4.1. Company Market Share Aanalysis

4.2. Porters Five Forces Analysis

CHAPTER 5. Global Biobanking Market Size and Forecast (2015 – 2025) (USD Million)

5.1. Global Biobanking Market, By Product and Services (USD Million)

5.1.1. Equipment

   5.1.1.1. Sample Transport Equipment

   5.1.1.2. Sample Analysis Equipment

   5.1.1.3. Storage Equipment

   5.1.1.4. Sample Processing Equipment

5.1.2. Consumables

   5.1.2.1. Analysis Consumables

   5.1.2.2. Processing Consumables

   5.1.2.3. Collection Consumables

   5.1.2.4. Storage Consumables

5.1.3. Service

   5.1.3.1. Processing Services

   5.1.3.2. Storage Services

   5.1.3.3. Transport Services

5.1.4. Software

5.2. Global Biobanking Market, By Sample Type (USD Million)

5.2.1. Nucleic Acids

5.2.2. Cell Lines

5.2.3. Blood Products and Services

5.2.4. Biological Fluids

5.2.5. Human Tissues

5.2.6. Others

5.3. Global Biobanking Market, By Storage Type (USD Million)

5.3.1. Automated Storage

5.3.2. Manual Storage

5.4. Global Biobanking Market, By Application (USD Million)

5.4.1. Life Science Research

5.4.2. Regenerative Medicine

5.4.3. Clinical Research

5.5. Global Biobanking Market, By End-User (USD Million)

5.5.1. Research Centers

5.5.2. Diagnostic Laboratories

5.5.3. Hospitals

CHAPTER 6. Global Biobanking Market, By Geography

6.1. North America Biobanking Market

6.1.1. North America Biobanking Market, By Product and Services (USD Million)

6.1.2. North America Biobanking Market, By Sample Type (USD Million)

6.1.3. North America Biobanking Market, By Storage Type (USD Million)

6.1.4. North America Biobanking Market, By Application (USD Million)

6.1.5. North America Biobanking Market, By End-User (USD Million)

6.1.6. North America Biobanking Market, By Country

   6.1.6.1. The United States

   6.1.6.2. Canada

   6.1.6.3. Mexico

6.2. Europe Biobanking Market

6.2.1. Europe Biobanking Market, By Product and Services (USD Million)

6.2.2. Europe Biobanking Market, By Sample Type (USD Million)

6.2.3. Europe Biobanking Market, By Storage Type (USD Million)

6.2.4. Europe Biobanking Market, By Application (USD Million)

6.2.5. Europe Biobanking Market, By End-User (USD Million)

6.2.6. Europe Biobanking Market, By Country

   6.2.6.1. Germany

   6.2.6.2. Netherlands

   6.2.6.3. United Kingdom

   6.2.6.4. Spain

   6.2.6.5. Italy

   6.2.6.6. France

   6.2.6.7. Poland

   6.2.6.8. Austria

   6.2.6.9. Denmark

   6.2.6.10. Hungary

   6.2.6.11. Estonian

   6.2.6.12. Romania

   6.2.6.13. Sweden

   6.2.6.14. Rest of Europe

6.3. Asia-Pacific Biobanking Market

6.3.1. Asia-Pacific Biobanking Market, By Product and Services (USD Million)

6.3.2. Asia-Pacific Biobanking Market, By Sample Type (USD Million)

6.3.3. Asia-Pacific Biobanking Market, By Storage Type (USD Million)

6.3.4. Asia-Pacific Biobanking Market, By Application (USD Million)

6.3.5. Asia-Pacific Biobanking Market, By End-User (USD Million)

6.3.6. Asia-Pacific Biobanking Market, By Country

   6.3.6.1. China

   6.3.6.2. Japan

   6.3.6.3. Australia

   6.3.6.4. Taiwan

   6.3.6.5. Malaysia

   6.3.6.6. Singapore

   6.3.6.7. South Korea

   6.3.6.8. India

   6.3.6.9. Rest of Asia-Pacific

6.4. Central & South America Biobanking Market

6.4.1. Central & South America Biobanking Market, By Product and Services (USD Million)

6.4.2. Central & South America Biobanking Market, By Sample Type (USD Million)

6.4.3. Central & South America Biobanking Market, By Storage Type (USD Million)

6.4.4. Central & South America Biobanking Market, By Application (USD Million)

6.4.5. Central & South America Biobanking Market, By End-User (USD Million)

6.4.6. Central & South America Biobanking Market, By Country

   6.4.6.1. Argentina

   6.4.6.2. Brazil

   6.4.6.3. Rest of Central & South America

6.5. Middle East and Africa Biobanking Market

6.5.1. Middle East and Africa Biobanking Market, By Product and Services (USD Million)

6.5.2. Middle East and Africa Biobanking Market, By Sample Type (USD Million)

6.5.3. Middle East and Africa Biobanking Market, By Storage Type (USD Million)

6.5.4. Middle East and Africa Biobanking Market, By Application (USD Million)

6.5.5. Middle East and Africa Biobanking Market, By End-User (USD Million)

6.5.6. Middle East and Africa Biobanking Market, By Country

   6.5.6.1. Saudi Arabia

   6.5.6.2. Qatar

   6.5.6.3. South Africa

   6.5.6.4. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. Cryo Bio System.

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. BioLifeSolutions Inc.

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. Brooks Automation, Inc

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. Thermo Fisher Scientific Inc.

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. Tecan Group Ltd.

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. SOL Group

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Hamilton Company

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. AUTOGEN INC.

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Software Point

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. LVL technologies GmbH & Co. KG

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. DNA Genotek Inc.

7.11.1. Business Overview

7.11.2. Product and Service Offering

7.11.3. Financial Overview

7.11.4. Strategic Developments

7.12. ASKION

7.12.1. Business Overview

7.12.2. Product and Service Offering

7.12.3. Financial Overview

7.12.4. Strategic Developments

Enquiry Before Buying

[contact-form-7]

Global Biobanking Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation and Forecast 2025

Related Reports

  • Global Holter Monitoring Systems Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
    August 21, 2019
  • Global Medical Tapes Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2019-2025
    July 23, 2019
  • Global Vessel Sealing Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
    July 22, 2019
  • Global Healthcare E-commerce Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2019-2025
    July 17, 2019

The post Global Biobanking Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025 appeared first on Energias Market Research.



This post first appeared on Market Research Reports, Market Analysis, Market Survey, please read the originial post: here

Share the post

Global Biobanking Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025

×

Subscribe to Market Research Reports, Market Analysis, Market Survey

Get updates delivered right to your inbox!

Thank you for your subscription

×